Objective: Change the conversation with existing prescribers and challenge the status quo for how they are treating patients who are not on TASIGNA.
Description: A branded chapterized video highlighting the key facts about 1L CML and long-term effects with questions along the way for viewers to answer. Video will live on TASIGNA HCP website. Derivative materials include: Leave Behind, RTEs, and possible NPP drivers.
First-Hand Facts
This theme features a “peer-to-peer” style. The main character, a figure that conveys seriousness and credibility (possibly an ME), serves as the presenter.
They will introduce the topic at the beginning of each chapter and interact with the data as they discuss it, bringing it to life in memorable and engaging ways (e.g., holding data in their hands, walking along a line chart, manipulating it in some way, etc.).
